Fundraising Fox

LAVA Therapeutics

Founded 2016 · 3 known investors

lavatherapeutics.com ↗

LAVA Therapeutics develops bispecific gamma delta T cell engager immunotherapies through its Gammabody platform, designed to activate Vγ9Vδ2 T cells to target and kill cancer cells. The company operates in the oncology and cancer immunotherapy space.

BiotechHealthtech

Investors · 3

MRL Ventures FundCambridge · $25M
Sanofi VenturesCambridge · $5M
Ysios CapitalBarcelona · $5.4M – $21.6M

In the news

LAVA Therapeutics Announces $83 million Series C Financing to Advance Novel Immuno-Oncology Programs - Lava Therapeuticslavatherapeutics.com · Sep 2020LAVA Therapeutics Announces $83M Series – Ysios Capitalysioscapital.com · Sep 2020

Frequently asked questions

What does LAVA Therapeutics do?
LAVA Therapeutics develops bispecific gamma delta T cell engager immunotherapies through its Gammabody platform, designed to activate Vγ9Vδ2 T cells to target and kill cancer cells. The company operates in the oncology and cancer immunotherapy space.
Who are LAVA Therapeutics's investors?
LAVA Therapeutics's investors include MRL Ventures Fund, Sanofi Ventures, Ysios Capital.